The EORTC Cancer in the Elderly Task Force, a Protostar for EORTC's future

European Journal of Cancer, Supplement

Volumn 10, Issue 1, 2012, Pages 34-38

  Wildiers, Hans ^a   Brain, Etienne ^b   Penninckx, Bjorn ^c   Ring, Alistair ^d   Repetto, Lazzaro ^e   Soubeyran, Pierre ^f   Monfardini, Silvio ^g   Aapro, Matti ^h   Wedding, Ulrich ⁱ  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b INSTITUT CURIE   (France)

^c EORTC DATA CENTER   (Belgium)

^d ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^e INRCA   (Italy)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^h CLINIQUE DE GENOLIER   (Switzerland)

ⁱ JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Cancer; Elderly; EORTC; Geriatric oncology

Indexed keywords

ANTHRACYCLINE; CETUXIMAB; CISPLATIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 6; K RAS PROTEIN; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ADVANCED CANCER; AGING; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RESEARCH; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; COMORBIDITY; DAILY LIFE ACTIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; ELDERLY CARE; FUNCTIONAL STATUS; GERIATRIC CARE; HIGH RISK PATIENT; HUMAN; METHODOLOGY; MONOTHERAPY; OVERALL SURVIVAL; PATIENT ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 84858165551     PISSN: 13596349     EISSN: 18781217     Source Type: Journal    
DOI: 10.1016/S1359-6349(12)70008-3     Document Type: Article

References (17)

1. Aapro MS Launching the Journal of Geriatric Oncology: A historical milestone. J Geriatr Oncol 2010, 1(1):2-3.
2. Fentiman IS, Tirelli U, Monfardini S, et al. Cancer in the elderly: why so badly treated?. Lancet 1990, 335(8696):1020-1022.
3. Monfardini S, Chabner B Joint NCI-EORTC consensus meeting on neoplasia in the elderly. San Servolo Island, Venice, 15-16 October 1990. Eur J Cancer 1991, 27(5):653-654.
4. Extermann M, Aapro M, Audisio R, et al. Main priorities for the development of geriatric oncology: A worldwide expert perspective. J Geriatr Oncol 2011, 10.1016/j.jgo.2011.07.001.
5. Monfardini S, Sorio R, Boes GH, Kaye S, Serraino D Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studies. Cancer 1995, 76(2):333-338.
6. Tirelli U, Errante D, Van Glabbeke M, et al. CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998, 16(1):27-34.
7. Soubeyran P, Khaled H, MacKenzie M, et al. Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly: A phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment. J Geriatr Oncol 2011, 2(1):36-44.
8. Fentiman IS, Christiaens MR, Paridaens R, et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 2003, 39(3):309-316.
9. Repetto L, Biganzoli L, Koehne CH, et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003, 39(16):2264-2272.
10. Pallis AG, Fortpied C, Wedding U, et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010, 46(9):1502-1513.
11. Pallis AG, Ring A, Fortpied C, et al. EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Ann Oncol 2011, 22(8):1922-1926.
12. Soubeyran P, Bellera C, Goyard J, et al. Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. J Clin Oncol 2011, 29(Suppl). abstr 9001.
13. Talarico L, Chen G, Pazdur R Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004, 22(22):4626-4631.
14. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003, 21(7):1383-1389.
15. Johnson C, Fitzsimmons D, Gilbert J, et al. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15. Eur J Cancer 2010, 46(12):2242-2252.
16. Pallis AG, Gridelli C, van Meerbeeck JP, et al. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol 2010, 21(4):692-706.
17. Pallis AG, Papamichael D, Audisio R, et al. EORTC Elderly Task Force experts' opinion for the treatment of colon cancer in older patients. Cancer Treat Rev 2010, 36(1):83-90.